Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E

Journal of Virology

Volumn 77, Issue 4, 2003, Pages 2530-2538

  Bonavia, Aurelio ^a,c   Zelus, Bruce D ^a   Wentworth, David E ^a   Talbot, Pierre J ^b   Holmes, Kathryn V ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SPIKE GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; CORONAVIRUS; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR BINDING; SPIKE;

3T3 CELLS; AMINOPEPTIDASES; ANIMALS; BACULOVIRIDAE; BINDING SITES; CELLS, CULTURED; CORONAVIRUS 229E, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; SPODOPTERA; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS;

EID: 0037321751     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.4.2530-2538.2003     Document Type: Article

References (60)

1. Baker, K. A., R. E. Dutch, R. A. Lamb, and T. S. Jardetzky. 1999. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 3:309-319.
2. Beauchemin, N., P. Draber, G. Dveksler, P. Gold, S. Gray-Owen, F. Grunert, S. Hammarstrom, K. V. Holmes, A. Karlsson, M. Kuroki, S. H. Lin, L. Lucka, S. M. Najjar, M. Neumaier, B. Obrink, J. E. Shively, K. M. Skubitz, C. P. Stanners, P. Thomas, J. A. Thompson, M. Virji, S. von Kleist, C. Wagener, S. Watt, and W. Zimmermann. 1999. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res. 252:243-249.
3. Benbacer, L., E. Kut, L. Besnardeau, H. Laude, and B. Delmas. 1997. Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus. J. Virol. 71:734-737.
4. Bos, E0. C., W. Luytjes, and W. J. Spaan. 1997. The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity. J. Virol. 71:9427-9433.
5. Breslin, J. J., I. Mork, M. K. Smith, L. K. Vogel, E. M. Hemmila, A. Bonavia, P. J. Talbot, H. Sjöström, O. Norén, and K. V. Holmes. Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37°C. J. Virol., in press.
6. Correa, I., F. Gebauer, M. J. Bullido, C. Sune, M. F. Baay, K. A. Zwaagstra, W. P. Posthumus, J. A. Lenstra, and L. Enjuanes. 1990. Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. J. Gen. Virol. 71(Pt 2):271-279.
7. Delmas, B., J. Gelfi, E. Kut, H. Sjostrom, O. Noren, and H. Laude. 1994. Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. J. Virol. 68:5216-5224.
8. Delmas, B., J. Gelfi, R. L'Haridon, L. K. Vogel, H. Sjostrom, O. Noren, and H. Laude. 1992. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature 357:417-420.
9. Delmas, B., J. Gelfi, H. Sjostrom, O. Noren, and H. Laude. 1993. Further characterization of aminopeptidase-N as a receptor for coronaviruses. Adv. Exp. Med. Biol. 342:293-298.
10. Delmas, B., and H. Laude. 1990. Assembly of coronavirus spike protein into trimers and its role in epitope expression. J. Virol. 64:5367-5375.
11. Frana, M. F., J. N. Behnke, L. S. Sturman, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 56:912-920.
12. Fredericksen, B. L., and M. A. Whitt. 1995. Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity. J. Virol. 69:1435-1443.
13. Gallagher, T. M. 1997. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71:3129-3137.
14. Gebauer, F., W. P. Posthumus, I. Correa, C. Sune, C. Smerdou, C. M. Sanchez, J. A. Lenstra, R. H. Meloen, and L. Enjuanes. 1991. Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein. Virology 183:225-238.
15. Godet, M., J. Grosclaude, B. Delmas, and H. Laude. 1994. Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J. Virol. 68:8008-8016.
16. Hamre, D., and J. J. Procknow. 1966. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 121:190-193.
17. Hansen, G. H., B. Delmas, L. Besnardeau, L. K. Vogel, H. Laude, H. Sjostrom, and O. Noren. 1998. The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment. J. Virol. 72:527-534.
18. Hegyi, A., and A. F. Kolb. 1998. Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N. J. Gen. Virol. 79:1387-1391.
19. Holmes, K. V. 2001. Coronaviruses, p. 1187-1203. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 1, 4th ed. Lippincott-Raven Publishers, New York, N.Y.
20. Hunter, E., and R. Swanstrom. 1990. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157:187-253.
21. Jackson, T., W. Blakemore, J. W. Newman, N. J. Knowles, A. P. Mould, M. J. Humphries, and A. M. King. 2000. Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5β1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J. Gen. Virol. 81:1383-1391.
22. Jackson, T., A. Sharma, R. A. Ghazaleh, W. E. Blakemore, F. M. Ellard, D. L. Simmons, J. W. Newman, D. I. Stuart, and A. M. King. 1997. Arginineglycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin αvβ3 in vitro. J. Virol. 71:8357-8361.
23. Kolb, A. F., A. Hegyi, J. Maile, A. Heister, M. Hagemann, and S. G. Siddell. 1998. Molecular analysis of the coronavirus-receptor function of aminopeptidase N. Adv. Exp. Med. Biol. 440:61-67.
24. Kolb, A. F., A. Hegyi, and S. G. Siddell. 1997. Identification of residues critical for the human coronavirus 229E receptor function of human aminopeptidase N. J. Gen. Virol. 78(Pt 11):2795-2802.
25. Kolb, A. F., J. Maile, A. Heister, and S. G. Siddell. 1996. Characterization of functional domains in the human coronavirus HCV 229E receptor. J. Gen. Virol. 77(Pt 10):2515-2521.
26. Krempl, C., M. L. Ballesteros, G. Zimmer, L. Enjuanes, H. D. Klenk, and G. Herrler. 2000. Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. J. Gen. Virol. 81:489-496.
27. Krueger, D. K., S. M. Kelly, D. N. Lewicki, R. Ruffolo, and T. M. Gallagher. 2001. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion. J. Virol. 75:2792-2802.
28. Luo, Z. L., and S. R. Weiss. 1998. Mutational analysis of fusion peptide-like regions in the mouse hepatitis virus strain A59 spike protein. Adv. Exp. Med. Biol. 440:17-23.
29. Luytjes, W., L. S. Sturman, P. J. Bredenbeek, J. Charite, B. A. van der Zeijst, M. C. Horzinek, and W. J. Spaan. 1987. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology 161:479-487.
30. Malashkevich, V. N., B. J. Schneider, M. L. McNally, M. A. Milhollen, J. X. Pang, and P. S. Kim. 1999. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc. Natl. Acad. Sci. USA 96:2662-2667.
31. McIntosh, K., A. Z. Kapikian, K. A. Hardison, J. W. Hartley, and R. M. Chanock. 1969. Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J. Immunol. 102:1109-1118.
32. Raabe, T., B. Schelle-Prinz, and S. G. Siddell. 1990. Nucleotide sequence of the gene encoding the spike glycoprotein of human coronavirus HCV 229E. J. Gen. Virol. 71(Pt 5):1065-1073. .
33. Rao, P. V., S. Kumari, and T. M. Gallagher. 1997. Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology 229:336-348.
34. Rizzuto, C. D., R. Wyatt, N. Hernandez-Ramos, Y. Sun, P. D. Kwong, W. A. Hendrickson, and J. Sodroski. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953.
35. Sanchez, C. M., F. Gebauer, C. Sune, A. Mendez, J. Dopazo, and L. Enjuanes. 1992. Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology 190:92-105.
36. Sanchez, C. M., A. Izeta, J. M. Sanchez-Morgado, S. Alonso, I. Sola, M. Balasch, J. Plana-Duran, and L. Enjuanes. 1999. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J. Virol. 73:7607-7618.
37. Sato, S. B., K. Kawasaki, and S. Ohnishi. 1983. Hemolytic activity of influenza virus hemagglutinin glycoproteins activated in mildly acidic environments. Proc. Natl. Acad. Sci. USA 80:3153-3157.
38. Schultze, B., L. Enjuanes, and G. Herrler. 1995. Analysis of the sialic acid-binding activity of the transmissible gastroenteritis virus. Adv. Exp. Med. Biol. 380:367-370.
39. Sestak, K., I. Lanza, S. K. Park, P. A. Weilnau, and L. J. Saif. 1996. Contribution of passive immunity to porcine respiratory coronavirus to protection against transmissible gastroenteritis virus challenge exposure in suckling pigs. Am. J. Vet. Res. 57:664-671.
40. Storz, J., R. Rott, and G. Kaluza. 1981. Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment. Infect. Immun. 31:1214-1222.
41. Sune, C., C. Smerdou, I. M. Anton, P. Abril, J. Plana, and L. Enjuanes. 1991. A conserved coronavirus epitope, critical in virus neutralization, mimicked by internal-image monoclonal anti-idiotypic antibodies. J. Virol. 65:6979-6984.
42. Suzuki, H., and F. Taguchi. 1996. Analysis of the receptor-binding site of murine coronavirus spike protein. J. Virol. 70:2632-2636.
43. Tan, K., B. D. Zelus, R. Meijers, J. H. Liu, J. M. Bergelson, N. Duke, R. Zhang, A. Joachimiak, K. V. Holmes, and J. H. Wang. 2002. Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. EMBO J. 21:2076-2086.
44. Tresnan, D. B., and K. V. Holmes. 1998. Feline aminopeptidase N is a receptor for all group I coronaviruses. Adv. Exp. Med. Biol. 440:69-75.
45. Tsai, J. C., B. D. Zelus, K. V. Holmes, and S. R. Weiss. 2003. The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J. Virol. 77:841-850.
46. Tyrrell, D. A. 1979. Studies of rhinoviruses and coronaviruses at the Common Cold Unit, Salisbury, Wiltshire. Postgrad. Med. J. 55:117-121.
47. Tyrrell, D. A., M. L. Bynoe, and B. Hoorn. 1968. Cultivation of "difficult" viruses from patients with common colds. Br. Med. J. 1:606-610.
48. Wang, G., C. Deering, M. Macke, J. Shao, R. Burns, D. M. Blau, K. V. Holmes, B. L. Davidson, S. Perlman, and P. B. McCray, Jr. 2000. Human coronavirus 229E infects polarized airway epithelia from the apical surface. J. Virol. 74:9234-9239.
49. Wentworth, D. E., and K. V. Holmes. 2001. Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. J. Virol. 75:9741-9752.
50. Wessner, D. R., P. C. Shick, J. H. Lu, C. B. Cardellichio, S. E. Gagneten, N. Beauchemin, K. V. Holmes, and G. S. Dveksler. 1998. Mutational analysis of the virus and monoclonal antibody binding sites in MHVR, the cellular receptor of the murine coronavirus mouse hepatitis virus strain A59. J. Virol. 72:1941-1948.
51. White, J., K. Matlin, and A. Helenius. 1981. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J. Cell Biol. 89:674-679.
52. White, J. M. 1992. Membrane fusion. Science 258:917-924.
53. Wiley, D. C., and J. J. Skehel. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-394.
54. Wilson, I. A., and N. J. Cox. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:737-771.
55. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366-373.
56. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.
57. Wyatt, R., and J. Sodroski. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888.
58. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420-422.
59. Zelus, B. D., J. N. Schickli, D. M. Blau, S. R. Weiss, and K. V. Holmes. 2002. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37°C either by soluble murine CEACAM1 receptors or by pH 8. J. Virol. 77:830-840.
60. Zelus, B. D., D. R. Wessner, R. K. Williams, M. N. Pensiero, F. T. Phibbs, M. deSouza, G. S. Dveksler, and K. V. Holmes. 1998. Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities. J. Virol. 72:7237-7244.